Skip to content
Screener

Harrow HROW Total Revenue

Total Revenue at other companies

AbbVie logo
AbbVieABBV
$16.99B+10.2%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$37.59M+98.6%
Bausch + Lomb logo
Bausch + LombBLCO
$1.39B+9.1%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$10.79M+0.8%
Opko Health logo
Opko HealthOPK
$163.58M+4.3%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$2.52B+11.7%

Segments

By product

See full
VEVYE$29.39M+57.6%
IHEEZO$15.62M-14.8%
Other branded products$11.01M+111%
Other revenues$90K—

By segment

See full
Branded$56.11M+32.7%
Compounding$14.56M-32.2%

Other financials

Income statement

See full
Gross profit$50.4M+6.0%
Operating income-$11.0M-196%
Net income-$17.3M-446%
EPS (diluted)-$0.46-454%

Balance sheet

See full
Cash & equivalents$83.9M+58.4%
Total debt$308.4M-32.0%
Total equity$15.2M-69.4%
Total assets$416.8M+20.8%

Cash flow

See full
Operating cash flow-$9.8M—
CapEx$491.0K+196%
Free cash flow-$10.2M—

Valuation

See full
Market cap$1.15B-35.0%
Enterprise value$1.37B-33.7%
P/S4.2×-2.9×

Profitability

See full
Gross margin73.3%-1.3pp
Operating margin-1%-7.3pp
Net margin-19.8%+18.0pp
FCF margin1.8%+1.3pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity20.3×+11.2×
Current ratio2.2×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Harrow’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055271
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Revenues:
Product sales, net$70,571,000$63,657,000$114,701,000$111,402,000
Other revenues90,00085,000163,000171,000
Total revenues70,661,00063,742,000114,864,000111,573,000
Cost of sales(20,298,000)(16,230,000)(37,456,000)(31,754,000)
Gross profit50,363,00047,512,00077,408,00079,819,000
Operating expenses:
Selling, general and administrative53,298,00033,235,00096,528,00073,748,000

Item 1. Financial Statements

FAQ

What is Harrow's total revenue?
Harrow (HROW) reported total revenue of $70.66M in Q2 2026.
How has Harrow's total revenue changed year-over-year?
Harrow's total revenue increased by 10.9% year-over-year, from $63.74M to $70.66M.
What is the long-term trend for Harrow's total revenue?
Over 4 years (2021 to 2025), Harrow's total revenue has grown at a 39.2% compound annual growth rate (CAGR), from $72.48M to $272.3M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Harrow's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude